Torreya Partners/Deal History

Deal History

250+ total transactions representing $100B+ in aggregate value — 10 tracked below spanning 2024–2025 · 2 industries

250+

Total Transactions

Industries

2024–2025

Years Active

Healthcare Products6

Sugemalimab Out-License - Western EU and UK2025

Strategic acquirer: European Pharma Licensor

Advisor on out-license of Sugemalimab to Western EU and UK markets. Complex international licensing structure.

$192.5MSell SideSell Side Advisor

Multiple Biopharma IPOs and Follow-ons2025

Strategic acquirer: Public Markets

Joint bookrunning manager on multiple biopharma IPOs and follow-on offerings throughout 2024-2025.

$75M-$692.3MRecapitalizationCo Advisor

Pieris Pharmaceuticals HealthTech Advisory2024

Strategic acquirer: Strategic or PE Buyer

Sell-side advisor on Pieris Pharmaceuticals HealthTech transaction (Dec 2024).

Sell SideSell Side Advisor

SPAC Merger - Medtech Company2024

Acquired by: SPAC Investor Group

Financial advisor on SPAC merger for medtech company (Jul 2024).

$128MRecapitalizationSell Side Advisor

Biopharma Buy-Side Advisory2024

Strategic acquirer: Strategic Pharma Buyer

Buy-side advisor on biopharma acquisition (Oct 2024).

Buy SideBuy Side Advisor

Medtech Sell-Side M&A2024

Strategic acquirer: Strategic or PE Buyer

Exclusive sell-side advisor on medtech and healthcare M&A transactions (Jul 2024, Aug 2024).

$100M-$310MSell SideSell Side Advisor

Healthcare Services4

HealthTech Buy-Side Advisory2025

Strategic acquirer: Strategic Healthcare Buyer

Buy-side advisor on HealthTech acquisition (Feb 2025).

Buy SideBuy Side Advisor

Healthcare Services IPO - Joint Bookrunner2025

Strategic acquirer: Public Markets

Joint bookrunning manager on Healthcare Services IPO (May 2025).

$502.9MRecapitalizationCo Advisor

HealthTech Sell-Side Advisory2024

Strategic acquirer: Strategic or PE Buyer

Sell-side advisor on HealthTech acquisition (Dec 2024).

Sell SideSell Side Advisor

Healthcare Services Sell-Side Advisory2024

Strategic acquirer: Strategic Healthcare Buyer

Exclusive sell-side advisor on healthcare services transaction (Oct 2024).

Sell SideSell Side Advisor